Announcements Trials
Browse Landscape

Phase

Phase 2 73Phase 3 47Phase 1 19Phase 1/2 9Phase NA 7Phase 4 7Phase 2/3 4Phase EARLY_PHASE1 2

Status

Completed 4Withdrawn 1Unknown 1Terminated 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Prostatic Neoplasms 6Primary Dysautonomias 1Kidney Diseases 1Hypertension 1Advanced Prostate Cancer 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 4 × Interventional × bicalutamide × Clear all
NCT05700903 2026-03-02

ARCH

University of Colorado, Denver

Phase 4 Completed
10 enrolled
Genitourinary

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

NCT03971110 2022-12-16

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

AstraZeneca

Phase 4 Terminated
9 enrolled
Genitourinary

Advanced Prostate Cancer

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Wonju Severance Christian Hospital

Phase 4 Unknown
164 enrolled
Genitourinary

Prostatic Neoplasms

NCT00470834 2017-02-27

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

GlaxoSmithKline

Phase 4 Completed
127 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00590213 2008-01-25

COMART

AstraZeneca

Phase 4 Completed
125 enrolled
Genitourinary

Prostatic Neoplasms

NCT00255268 2007-08-28

CMAB vs IMAB in Metastatic Prostate Cancer

AstraZeneca

Phase 4 Withdrawn
15 enrolled
Genitourinary

Prostatic Neoplasms

NCT00293696 2007-05-08

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Tampere University

Phase 4 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡